Stephanie Shafer – Psychopharmacology of ADHD: Deepening Clinician Insight into Medication Strategies

*** Proof of Product ***

Exploring the Essential Features of “Stephanie Shafer – Psychopharmacology of ADHD: Deepening Clinician Insight into Medication Strategies”

Speaker: Stephanie L. Shafer, MSN, ANP-BC, PMHNP-BC

Duration: 2 Hours 03 Minutes

Format: Audio and Video

Copyright: Mar 21, 2024  

Media Type: Digital Seminar

Description

Stephanie Shafer, MSN, ANP-BC, PMHNP-BC, will deliver an advanced and updated review of stimulant (e.g., methylphenidate, amphetamines) and non-stimulant (e.g., atomoxetine, guanfacine) medications, with a particular focus on understanding the mechanisms of action, how they differ, and how one might synergistically compliment another. Learn how these medications affect the brain’s chemistry and function to alleviate ADHD symptoms, allowing for a deeper appreciation of their therapeutic potential. Central to the discussion will be the identification of presenting symptomatology and the evaluating of treatment outcomes. This focus will provide the knowledge and skills needed to adeptly navigate the evolving landscape of ADHD management.

By the talk’s conclusion, you will possess a robust understanding of ADHD’s neurobiological basis, as well as a comprehensive knowledge of the mechanisms by which available medications act. Deliver personalizing care for patients with ADHD to enhance their quality of life and daily functioning to the future.

Speaker

Stephanie L. Shafer, MSN, ANP-BC, PMHNP-BC, works in a large private practice in Lansing, MI, providing clinical services to children, adolescents, and adults with psychiatric disorders, including ADHD, Bipolar Disorder, Depression, Anxiety, Obsessive-compulsive tendencies, Schizophrenia, Autism Spectrum Disorder, Traumatic Brain Injury, PTSD, and Personality Disorders. She has achieved considerable success treating these conditions. This success has largely resulted from the development of a structured model of care that includes a significant focus on clinical and background histories, identifying psychosocial stressors, and evaluating prior medical and psychiatric diagnoses (and treatment regimens associated with these conditions). This approach and model of medical management is essential to the effective delivery of psychiatric medications to this population.

From a clinical perspective, Stephanie has worked in a myriad of settings, including emergency medicine, primary care, and psychiatry, within a large urban hospital, community-based practice, clinics, and in a private-practice setting. Her transition from primary care to psychiatry evolved as a means of providing effective treatment for a growing population of underserved patients with psychiatric disorders.

Stephanie’s commitment to her specialty is evident. She completed a post-graduate degree specializing in psychiatry at Johns Hopkins University in Baltimore, MD, earned her Psychiatric Mental Health Nurse Practitioner certificate, and is a requested presenter, sharing her expertise with multidisciplinary healthcare audiences throughout the country.

Speaker Disclosures:
Financial: Stephanie Shafer is the owner and founder of Neurobehavioral Health and Wellness. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Stephanie Shafer is a member of the American Association of Nurse Practitioners.

Objectives

1. Explain the key neurobiological factors involved in ADHD, including neurotransmitter systems, brain regions implicated, and how they contribute to the symptoms of the disorder.
2. Evaluate the pharmacological treatments available for ADHD, including stimulant medications (e.g., methylphenidate, amphetamines) and non-stimulant mediations (e.g., atomoxetine, guanfacine).
3. Differentiate ADHD from common differentials and tailor pharmacotherapy to individual patients.
4. Analyze the effectiveness of ADHD medications, while also considering potential side effects.

Outline

Neurobiology of ADHD

• Neurotransmitter systems
• Brain regions implicated
• Contribution to symptoms

Examine Pharmacological Treatment Options

• Stimulant medications
  • Methylphenidate
  • Amphetamines
• Non-stimulant medications
  • Atomoxetine
  • Guanfacine, etc.
• Mechanisms of action
• Efficacy and effectiveness
• Differences and combinations

Individualized Treatment Strategies

• Differential diagnosis
  • Distinguish ADHD from common differentials
  • Consideration of comorbid psychiatric conditions
• Tailoring pharmacotherapy
  • Customize treatment plans based on individual patient profiles
  • Adjust dosage and medication type as needed
• Address overlapping symptomatology
  • Strategies to manage symptoms that overlap with other disorders
  • Coordinate care with other healthcare providers

Evaluate Treatment Outcomes & Side Effects

• Effectiveness of Medications
  • Reduction of ADHD symptoms
  • Improvement in daily functioning
  • Cognitive and emotional beliefs
• Side Effects
  • Common side effects of ADHD medications
  • Strategies to minimize side effects

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/